Ocular Oncology is a specialized field of cancer research and clinical practice that focuses on tumors affecting the eye and its surrounding structures. These cancers may originate within ocular tissues or spread to the eye from other parts of the body. Because the eye contains delicate structures responsible for vision, accurate diagnosis and precise treatment are essential. Scientific advances in this field are frequently discussed at global research forums such as an Oncology Conference, where specialists share developments in imaging, diagnosis, and treatment approaches for eye cancer tumors.

Ocular oncology encompasses a variety of malignancies that arise in different parts of the eye, including the retina, choroid, conjunctiva, and eyelid. Some of the most recognized primary ocular cancers include uveal melanoma, retinoblastoma, and conjunctival carcinoma. These tumors develop when genetic mutations alter normal cell growth and regulation within ocular tissues. Although ocular cancers are relatively rare compared with other malignancies, they require highly specialized diagnostic and therapeutic expertise because they can threaten both vision and life if not treated promptly.

Early detection of ocular tumors plays a critical role in preserving visual function and preventing disease progression. Patients may present with symptoms such as blurred vision, visual field disturbances, eye pain, or visible changes in eye appearance. In some cases, ocular tumors are discovered during routine eye examinations before symptoms develop. Diagnostic evaluation often includes advanced imaging techniques such as ocular ultrasound, optical coherence tomography, and fundus photography. These methods help clinicians visualize tumor size, location, and growth patterns while guiding treatment planning.

Treatment approaches in ocular oncology depend on the type of tumor, its size, and its location within the eye. Options may include laser therapy, radiation therapy, surgical removal of tumors, or systemic treatments in cases of metastatic disease. Modern techniques aim to control tumor growth while preserving vision whenever possible. Researchers continue to investigate new therapies, targeted treatments, and improved diagnostic technologies that enhance early detection and treatment outcomes for patients with ocular cancers.